ORIC compared with TRVI: revenue, margins and what each company keeps, and the suppliers and customers both name

ORICOric Pharmaceuticals, Inc.

Mkt capRevenueRevenue

TRVITrevi Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ORICOric Pharmaceuticals, Inc.

TRVITrevi Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ORIC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±44.4%▲+27.08%×0.61

Q1 FY26±47.2%▼−0.62%×0.01

Feb 24 '26±40.3%▲+14.60%×0.36

Nov 14 '25±31.1%▲+0.49%×0.02

TRVI

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.8%▲+0.05%×0.01

May 6 '26±8.2%▼−2.73%×0.33

= impliedORIC realized, solidTRVI realized, hatchedOne scale, both sides: full bar = 48%× = |realized| ÷ impliedspan: ORIC 263d · TRVI 142dSource: market data

Apr 17 '26

±17.5%

▲+4.75%

×0.27

Q1 FY26±11.9%▼−4.47%×0.38

ORICOric Pharmaceuticals, Inc.

9.25▲+2.87%· post 9.38

Mkt cap$957.8M

TRVITrevi Therapeutics, Inc.

13.54▼−1.96%· post 13.54

ClosedOct 30 '26

Mkt cap$1.9B

Compare

ClosedOct 30 '26

ORICOric Pharmaceuticals, Inc.

TRVITrevi Therapeutics, Inc.

9.25▲+2.87%post 9.38

Price

13.54▼−1.96%post 13.54

$957.8M

Mkt cap

$1.9B

ORIC9.25▲+2.87%vsTRVI13.54▼−1.96%ClosedOct 30 '26